— Know what they know.
Not Investment Advice
Also trades as: CING (NASDAQ) · $vol 2M

CINGW NASDAQ

Cingulate Inc.
1W: -24.2% 1M: -44.0% 3M: -81.0% YTD: -91.5% 1Y: -89.8% 3Y: -97.7%
$0.01
+0.00 (+0.00%)
 
Weekly Expected Move ±54.3%
$-0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 29 · $34443 mcap · 7M float · 0.296% daily turnover · Short 78% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$541K +17.2% ▲
Operating Income
-$20M -27.4% ▼
Net Income
-$22M -44.4% ▼
EPS (Diluted)
$-4.13 +59.5% ▲
EBITDA
-$19M -30.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$808K$622K$583K$653K$541K
Gross Profit-$808K-$622K-$583K-$653K-$541K
Gross Margin—————
R&D Expenses$8M$9M$15M$9M$10M
SG&A Expenses$12M$9M$7M$6M$10M
Operating Expenses$20M$17M$22M$15M$19M
Operating Income-$21M-$18M-$23M-$16M-$20M
Operating Margin—————
Interest Expense$33K$174K$0$0$924K
Income Before Tax-$21M-$18M-$24M-$16M-$22M
Tax Expense$0$0$0$0$0
Net Income-$21M-$18M-$24M-$16M-$22M
Net Margin—————
EPS (Diluted)$-55.80$-31.20$-311.99$-10.20$-4.13
EBITDA-$20M-$17M-$23M-$15M-$19M
Shares Outstanding1M1M2M4M5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms